Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3283046 | Clinical Gastroenterology and Hepatology | 2011 | 7 Pages |
Abstract
Most patients with HSTCL who received long-term therapy (at least 2 y) with thiopurines for IBD were men younger than 35 years old. There were no reported cases of HSTCL in patients with IBD who received only anti-TNF therapy. Physicians should consider giving thiopurines and anti-TNF agents to young male patients with IBD only in cases in which a clear benefit is expected, such as in early stage disease in untreated patients or possibly in very severe cases.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
David S. Kotlyar, Mark T. Osterman, Robert H. Diamond, David Porter, Wojciech C. Blonski, Mariusz Wasik, Sami Sampat, Manuel Mendizabal, Ming V. Lin, Gary R. Lichtenstein,